Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MIRANA THERAPEUTICS ApS
APS
Dissolved
CVR 35208046
Biskop Svanes Vej 30
Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100
Est. 2013
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2017
DKK 0
EBITDA margin
—
-37% vs 2016
Equity ratio
100.0%
Financial strength
Net profit 2017
DKK -4K
-37% vs 2016
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2013
0M
0%
2014
0M
0%
2015
0M
0%
2016
0M
0%
2017
Key figures
Annual report 2017
Revenue
DKK 0
—
EBITDA
DKK -5K
-37%
Net profit
DKK -4K
-37%
Total assets
DKK 60K
-6%
Equity
DKK 60K
-6%
Employees
—
—
Company information
Legal name
MIRANA THERAPEUTICS ApS
CVR number
35208046
Legal form
Anpartsselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
22. marts 2013
Share capital
DKK 80.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2017-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren og bestyrelsesformanden i forening eller af den samlede bestyrelse.
Contact
Address
Biskop Svanes Vej 30
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Forskning og eksperimentel udvikling indenfor bioteknologi
Companies in Rudersdal
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2013
0M
2014
0M
2015
0M
2016
0M
2017
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2013
0M
2014
0M
2015
0M
2016
0M
2017
Income statement
DKK thousands
Item
2013
2014
2015
2016
2017
Revenue
-13
29
284
112
0
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-13
-4
-0
-4
-5
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-13
-4
-0
-4
-5
Net financials
-1
0
0
0
0
Profit before tax
-14
-4
-0
-4
-5
Tax
-3
-1
-0
-1
-1
Net profit
-10
-3
-0
-3
-4
Balance sheet
DKK thousands
Item
2013
2014
2015
2016
2017
Total assets
70
463
179
64
60
Equity
70
67
67
64
60
Long-term debt
0
0
0
0
0
Short-term debt
0
396
112
0
0
Total debt
0
396
112
0
0
Financial ratios
5-year trend
EBITDA margin
-516000.0%
This company
15.8%
Market median
-3265923% vs market
2013
2017
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2013
2017
Return on equity
-6.7%
This company
18.4%
Market median
-136% vs market
2013
2017
Net profit margin
-404100.0%
This company
8.1%
Market median
-4988989% vs market
2013
2017
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2013
2017
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2013
2017
Annual reports & filings
Annual report 2017
Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
View
PDF
Annual report 2015
Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
View
PDF
Annual report 2014
Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
View
PDF
Annual report 2013
Filed via CVR / Virk · Period 2013-03-22 – 2013-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Markus Sakari Kauppinen
Individual
25–33.32%
25–33.32%
2013
Niels Abrahamsen
Individual
25–33.32%
25–33.32%
2013
Andreas Petri
Individual
25–33.32%
25–33.32%
2013
Henrik Frydendal Havmose
Individual
25–33.32%
25–33.32%
2013
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of MIRANA THERAPEUTICS ApS also hold positions in
0
other companies.
Person
Role here
Other companies